Oncology and immunotherapy
Research activity includes oncological immunotherapies with attention to treatment-related safety, particularly infusion-related reactions and hypersensitivity events associated with monoclonal antibodies.
- Infusion safety in cancer treatment
- Immune-mediated adverse reactions
- Monoclonal antibody tolerability
The clinical focus in this area is centered on adverse event monitoring during antineoplastic treatment.
Inflammatory bowel disease
Clinical interest extends to gastrointestinal inflammation and chronic immune-mediated disorders affecting the digestive tract.
- Intestinal inflammation
- Chronic bowel disorders
- Immune dysregulation
This area reflects involvement in conditions requiring ongoing inflammatory disease management.
Rheumatic disease
Research activity also covers rheumatology, with interest in autoimmune and inflammatory musculoskeletal conditions.
- Autoimmune joint disease
- Systemic inflammation
- Musculoskeletal immune disorders
The therapeutic emphasis includes diseases commonly treated with biologic therapies and other immune-modulating approaches.
